Further investigation evaluating parathyroid hormone and calcitonin levels or changes to the RANK/RANK-L pathway will be required to fully understand how nabilone, via CB1/CB2 receptors protects the bone from the tumor burden. This evidence concerns the gene TNFSF11 and neoplasm.